Literature DB >> 12633888

Intracerebroventricular injection of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibits feeding in chicks.

Tetsuya Tachibana1, Shin Saito, Shozo Tomonaga, Tomo Takagi, Ei-Suke Saito, Tim Boswell, Mitsuhiro Furuse.   

Abstract

Previous research has indicated an involvement of glucagon superfamily peptides in the regulation of feeding in the domestic chick brain. However the possible roles of vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating polypeptide-38 (PACAP) have not yet been investigated. We therefore examined the effect of intracerebroventricular (ICV) injections of VIP or PACAP on food intake in chicks. ICV injection of both VIP and PACAP significantly inhibited food intake over 4 h at doses ranging from 12 to 188 pmol. Subsequently, we compared the anorexic effect the glucagon superfamily peptides VIP, PACAP, growth hormone-releasing factor (GRF) and glucagon-like peptide-1 (GLP-1) after ICV injection at an equimolar dose (12 pmol). All four peptides significantly inhibited food intake, although the anorexic effects of VIP and PACAP were weaker than those of GRF and GLP-1. These findings support the hypothesis that glucagon superfamily peptides play an important role in the regulation of appetite in the chick brain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12633888     DOI: 10.1016/s0304-3940(03)00017-x

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  19 in total

1.  CRF mediates the anxiogenic and anti-rewarding, but not the anorectic effects of PACAP.

Authors:  Riccardo Dore; Attilio Iemolo; Karen L Smith; Xiaofan Wang; Pietro Cottone; Valentina Sabino
Journal:  Neuropsychopharmacology       Date:  2013-05-09       Impact factor: 7.853

Review 2.  Pituitary adenylate cyclase activating polypeptide in stress-related disorders: data convergence from animal and human studies.

Authors:  Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2014-12-09       Impact factor: 13.382

3.  Oxytocin participates on the effects of vasoactive intestinal peptide on food intake and plasma parameters.

Authors:  Andressa B Martins; Marcela C Garnica-Siqueira; Dimas A M Zaia; Cássia Thaïs B V Zaia; Ernane T Uchôa
Journal:  Mol Cell Biochem       Date:  2017-07-27       Impact factor: 3.396

4.  Quantitative Mass Spectrometry Reveals Food Intake-Induced Neuropeptide Level Changes in Rat Brain: Functional Assessment of Selected Neuropeptides as Feeding Regulators.

Authors:  Hui Ye; Jingxin Wang; Zichuan Tian; Fengfei Ma; James Dowell; Quentin Bremer; Gaoyuan Lu; Brian Baldo; Lingjun Li
Journal:  Mol Cell Proteomics       Date:  2017-09-01       Impact factor: 5.911

5.  PACAP in the BNST produces anorexia and weight loss in male and female rats.

Authors:  Margaret Kocho-Schellenberg; Kimberly R Lezak; Olivia M Harris; Erin Roelke; Niklas Gick; Inyop Choi; Shaquille Edwards; Emily Wasserman; Donna J Toufexis; Karen M Braas; Victor May; Sayamwong E Hammack
Journal:  Neuropsychopharmacology       Date:  2014-01-17       Impact factor: 7.853

6.  Feeding and metabolism in mice lacking pituitary adenylate cyclase-activating polypeptide.

Authors:  Bruce A Adams; Sarah L Gray; Emma R Isaac; Antonio C Bianco; Antonio J Vidal-Puig; Nancy M Sherwood
Journal:  Endocrinology       Date:  2007-12-27       Impact factor: 4.736

7.  PAC1 receptor antagonism in the bed nucleus of the stria terminalis (BNST) attenuates the endocrine and behavioral consequences of chronic stress.

Authors:  Carolyn W Roman; Kim R Lezak; Matthew J Hartsock; William A Falls; Karen M Braas; Alan B Howard; Sayamwong E Hammack; Victor May
Journal:  Psychoneuroendocrinology       Date:  2014-05-27       Impact factor: 4.905

Review 8.  Pleiotropic pituitary adenylate cyclase-activating polypeptide (PACAP): Novel insights into the role of PACAP in eating and drug intake.

Authors:  Andrew T Gargiulo; Genevieve R Curtis; Jessica R Barson
Journal:  Brain Res       Date:  2019-12-26       Impact factor: 3.252

9.  Regulation of Appetite, Body Composition, and Metabolic Hormones by Vasoactive Intestinal Polypeptide (VIP).

Authors:  John P Vu; Muriel Larauche; Martin Flores; Leon Luong; Joshua Norris; Suwan Oh; Li-Jung Liang; James Waschek; Joseph R Pisegna; Patrizia M Germano
Journal:  J Mol Neurosci       Date:  2015-04-23       Impact factor: 3.444

10.  PACAP intraperitoneal treatment suppresses appetite and food intake via PAC1 receptor in mice by inhibiting ghrelin and increasing GLP-1 and leptin.

Authors:  John P Vu; Deepinder Goyal; Leon Luong; Suwan Oh; Ravneet Sandhu; Joshua Norris; William Parsons; Joseph R Pisegna; Patrizia M Germano
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-03       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.